Insider trades
Yeleswaram Krishnaswamy
Yeleswaram Krishnaswamy made 0 buys and 9 sales on the open market in the last 12 months at Rapport Therapeutics, Inc. Each trade with the role, price and filing.
Insider trades
Where they report
| Company | Role | Holding after | Latest trade |
|---|---|---|---|
| Rapport Therapeutics, Inc. NASDAQ:RAPP | Chief Development Officer | 196K | Aug 25, 2026 |
Open-market trades, newest first
| Company | Date | Trade | Shares | Price | Value | Holding after | Filed |
|---|---|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. NASDAQ:RAPP | Aug 25, 2026 | Sale | 16,201 | US$51.06 | US$827K | 196K | Aug 26, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | Aug 25, 2026 | Sale | 20,799 | US$50.31 | US$1.05M | 212K | Aug 26, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | Aug 24, 2026 | Sale | 13,160 | US$50.00 | US$658K | 233K | Aug 26, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | Aug 19, 2026 | Sale | 404 | US$49.90 | US$20,160 | 246K | Aug 20, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | Apr 17, 2026 | Sale | 20,225 | US$39.99 | US$809K | 246K | Apr 21, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | Apr 14, 2026 | Sale | 10,200 | US$35.08 | US$358K | 267K | Apr 14, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | Apr 13, 2026 | Sale | 9,165 | US$34.97 | US$321K | 277K | Apr 14, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | Apr 10, 2026 | Sale | 500 | US$34.98 | US$17,490 | 286K | Apr 14, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | Apr 8, 2026 | Sale | 360 | US$34.90 | US$12,564 | 287K | Apr 9, 2026 |